Table 2.
Stroke characteristics.
| TOAST n (%) | ||
| n= 66 | Large artery atherosclerosis | 7 (10.6) |
| Cardioembolic | 18 (27.3) | |
| Small vessel | 3 (4.6) | |
| Other etiology | 11 (16.7) | |
| Cryptogenic | 27(40.9) | |
| Large vessel occlusion n (%) | ||
| n=91 | Yes | 60(65.9) |
| No | 31(34.1) | |
| Reperfusion therapy n (%) | ||
| n=152 | Thrombolysis | 14 (9.2) |
| Endovascular treatment | 11 (7.2) | |
| Thrombolysis + Endovascular treatment | 18 (11.8) | |
| None | 109(71.7) | |
| Medical management n (%) | ||
| n=115 | Anticoagulation | 51 (44.4) |
| Antiplatelet | 30 (26.1) | |
| Dual antiplatelet therapy | 16 (13.9) | |
| Anticoagulation + antiplatelet | 2 (1.7) | |
| None | 16 (13.9) |
TOAST Trial of ORG 10172 in Acute Stroke Treatment Criteria.